Search Results - Lorenzo Gerratana

Refine Results
  1. 1

    Editorial: Cancer evolution: From biological insights to therapeutic opportunities by Andrew A. Davis, Lorenzo Gerratana, Marco Mina

    Published in Frontiers in Genetics (2022-08-01)
    Get full text
    Article


  2. 2

    Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring? by Mara S. Serafini, Elisabetta Molteni, Eleonora Nicolò, Lorenzo Gerratana, Carolina Reduzzi, Massimo Cristofanilli

    Published in The Journal of Liquid Biopsy (2024-03-01)
    Get full text
    Article


  3. 3

    Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions by Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, Lorenzo Gerratana, Margherita Nuti, Marco Orleni, Marco Orleni, Sara Gagno, Elena De Mattia, Fabio Puglisi, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Roncato, Rossana Roncato

    Published in Frontiers in Pharmacology (2024-09-01)
    Get full text
    Article


  4. 4

    Mapping breast cancer therapy with circulating tumor cells: The expert perspective by Lorenzo Gerratana, Caterina Gianni, Eleonora Nicolò, Letizia Pontolillo, Francois-Clement Bidard, Carolina Reduzzi, Massimo Cristofanilli

    Published in Breast (2025-06-01)
    Get full text
    Article


  5. 5

    Patient preferences for treatments in hormone receptor-positive/HER2-negative metastatic breast cancer in Italy: a discrete choice experiment study by Grazia Arpino, Carmine De Angelis, Lorenzo Gerratana, Matteo Lambertini, Sarah Igidbashian, Rosanna Gramigna, Xavier Guillaume

    Published in BMC Cancer (2025-05-01)
    Get full text
    Article


  6. 6

    Beyond Hormone Receptors: liquid biopsy tools to unveil new clinical meanings and empower therapeutic decision-making in Luminal-like metastatic breast cancer by Brenno Pastò, Riccardo Vida, Arianna Dri, Lorenzo Foffano, Serena Della Rossa, Lorenzo Gerratana, Fabio Puglisi

    Published in Breast (2025-02-01)
    Get full text
    Article


  7. 7

    Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer by Lorenzo Gerratana, Lorenzo Gerratana, Debora Basile, Debora Basile, Alessandra Franzoni, Lorenzo Allegri, Davide Viotto, Carla Corvaja, Carla Corvaja, Lucia Bortot, Lucia Bortot, Elisa Bertoli, Elisa Bertoli, Silvia Buriolla, Silvia Buriolla, Giada Targato, Giada Targato, Lucia Da Ros, Stefania Russo, Marta Bonotto, Barbara Belletti, Gustavo Baldassarre, Giuseppe Damante, Fabio Puglisi, Fabio Puglisi

    Published in Frontiers in Oncology (2020-09-01)
    Get full text
    Article


  8. 8

    Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel by Alessandra Narcisi, Vito Di Lernia, Maria Esposito, Vittorio Forte, Silvia Mariel Ferrucci, Lorenzo Gerratana, Pietro Morrone, Saverio Muscoli, Maddalena Napolitano, Michela Ortoncelli, Marina Talamonti

    Published in Dermatology and Therapy (2025-03-01)
    Get full text
    Article


  9. 9

    Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II by João Pessoa, João Pessoa, Maria Teresa Valenti, Nadège Bellance, Paula Chiarella, Tamrat Abebe, Lorenzo Gerratana, Carlos Pérez-Plasencia, Carlos Pérez-Plasencia, Julia Kzhyshkowska, Julia Kzhyshkowska, Julia Kzhyshkowska, Julia Kzhyshkowska

    Published in Frontiers in Oncology (2023-07-01)
    Get full text
    Article


  10. 10

    Landscape of circulating tumour DNA in metastatic breast cancer by Andrew A. Davis, Saya Jacob, Lorenzo Gerratana, Ami N. Shah, Firas Wehbe, Neelima Katam, Qiang Zhang, Lisa Flaum, Kalliopi P. Siziopikou, Leonidas C. Platanias, William J. Gradishar, Amir Behdad, Massimo Cristofanilli

    Published in EBioMedicine (2020-08-01)
    Get full text
    Article


  11. 11

    Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity by Tania Rossi, Sara Bandini, Michele Zanoni, Michela Cortesi, Michela Palleschi, Erika Bandini, Andrea Rocca, Giulia Gallerani, Ivan Vannini, Meropi Plousiou, Lorenzo Gerratana, Antonino Musolino, Giovanni Tallini, Giovanni Martinelli, Ugo De Giorgi, Paola Ulivi

    Published in Experimental Hematology & Oncology (2025-05-01)
    Get full text
    Article


  12. 12

    An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer by Rossana Roncato, Lorenzo Gerratana, Lorenza Palmero, Lorenza Palmero, Sara Gagno, Ariana Soledad Poetto, Elena Peruzzi, Martina Zanchetta, Bianca Posocco, Elena De Mattia, Giovanni Canil, Martina Alberti, Martina Alberti, Marco Orleni, Giuseppe Toffoli, Fabio Puglisi, Fabio Puglisi, Erika Cecchin

    Published in Frontiers in Pharmacology (2022-07-01)
    Get full text
    Article


  13. 13

    Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer by Linda Cucciniello, Eva Blondeaux, Claudia Bighin, Simona Gasparro, Stefania Russo, Arianna Dri, Palma Pugliese, Andrea Fontana, Enrico Cortesi, Antonella Ferzi, Ferdinando Riccardi, Valentina Sini, Luca Boni, Alessandra Fabi, Filippo Montemurro, Michelino De Laurentiis, Grazia Arpino, Lucia Del Mastro, Lorenzo Gerratana, Fabio Puglisi

    Published in npj Breast Cancer (2024-12-01)
    Get full text
    Article


  14. 14

    Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects by Giulia Brisotto, Marcella Montico, Matteo Turetta, Stefania Zanussi, Maria Rita Cozzi, Roberto Vettori, Romina Boschian Boschin, Lorenzo Vinante, Fabio Matrone, Alberto Revelant, Elisa Palazzari, Roberto Innocente, Giuseppe Fanetti, Lorenzo Gerratana, Mattia Garutti, Camilla Lisanti, Silvia Bolzonello, Milena Sabrina Nicoloso, Agostino Steffan, Elena Muraro

    Published in Viruses (2023-05-01)
    Get full text
    Article


  15. 15

    Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor... by Lorenzo Gerratana, Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah, Charles S. Dai, Carolina Reduzzi, Paolo D’Amico, Firas Wehbe, Arielle Medford, Seth A. Wander, William J. Gradishar, Amir Behdad, Fabio Puglisi, Cynthia X. Ma, Aditya Bardia, Massimo Cristofanilli

    Published in Breast Cancer Research (2023-10-01)
    Get full text
    Article


  16. 16

    Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy by Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, Federica Miglietta, Maria Vittoria Dieci, Roberta Mazzeo, Armando Orlandi, Lorenzo Gerratana, Antonella Palazzo, Alessandra Fabi, Ida Paris, Antonio Franco, Gianluca Franceschini, Elena Fiorio, Sara Pilotto, Valentina Guarneri, Fabio Puglisi, Pierfranco Conte, Michele Milella, Giovanni Scambia, Giampaolo Tortora, Emilio Bria

    Published in Therapeutic Advances in Medical Oncology (2023-03-01)
    Get full text
    Article


  17. 17

    Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer by Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco Cognetti, Lucia Del Mastro

    Published in npj Breast Cancer (2021-06-01)
    Get full text
    Article


  18. 18

    Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics by Lorenzo Foffano, Alessandra Franzoni, Elisabetta Molteni, Fabiola Giudici, Arianna Dri, Debora Basile, Linda Cucciniello, Silvia Buriolla, Claudia Noto, Stefania Russo, Elena Nascimbeni, Silvia Bolzonello, Brenno Pastò, Serena Della Rossa, Lorenzo Allegri, Marta Bonotto, Alessandro Marco Minisini, Barbara Belletti, Giuseppe Damante, Lorenzo Gerratana, Fabio Puglisi

    Published in Translational Oncology (2025-09-01)
    Get full text
    Article


  19. 19

    Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer by Luca Licata, Giulia Viale, Mario Giuliano, Giuseppe Curigliano, Mariana Chavez-MacGregor, Julia Foldi, Oluchi Oke, Joseph Collins, Lucia Del Mastro, Fabio Puglisi, Filippo Montemurro, Claudio Vernieri, Lorenzo Gerratana, Sara Giordano, Alessia Rognone, Lorenzo Sica, Oreste Davide Gentilini, Stefano Cascinu, Lajos Pusztai, Antonio Giordano, Carmen Criscitiello, Giampaolo Bianchini

    Published in npj Breast Cancer (2023-06-01)
    Get full text
    Article


  20. 20

    The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients by Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, Francesco Cortiula, Lorenzo Gerratana, Valentina Fanotto, Camilla Lisanti, Giacomo Pelizzari, Elena Ongaro, Michele Bartoletti, Silvio Ken Garattini, Victoria Josephine Andreotti, Anna Bacco, Donatella Iacono, Marta Bonotto, Mariaelena Casagrande, Paola Ermacora, Fabio Puglisi, Nicoletta Pella, Gianpiero Fasola, Giuseppe Aprile, Giovanni G. Cardellino

    Published in Journal of Cachexia, Sarcopenia and Muscle (2019-04-01)
    Get full text
    Article


Search Tools: